PRAX Q1 2026 Earnings Narrowerthanexpected loss as Praxis Precision Medicines advances pipeline LOW Q1 2026 Earnings EPS Tops Estimates Amid Modest Revenue Headwinds ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution VERX Q1 2026 Earnings Modest EPS Surprise Marks Steady Performance MDU Q1 2026 Earnings EPS Misses Estimates by 72 Stock Gains 15